# US 5,858,755 A · Lipase from human gastric mucosal tissue

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 5,858,755 A
- Document ID: US5858755A
- Status: Granted
- Kind: A
- Application number: 08/735,956
- Filed: 1996-10-23
- Granted: 1999-01-12
- Earliest claimed: 1984-08-21
- Assignees: Celltech Limited
- Inventors: Peter Anthony Lowe
- Web page: https://patentgrep.com/patent/US5858755A

## CPC

- C12N 9/20: Triglyceride splitting, e.g. by means of lipase
- C07K 2319/00: Fusion polypeptide
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

A human gastric lipase protein for use in the treatment of lipase deficiency. A process is described for producing gastric lipase using recombinant DNA technology to produce a host organism (for example E. coli) capable of producing a methionine-gastric lipase or precursor of the gastric lipase which may be cleaved to yield the gastric lipase. The host organism is transformed with a vector including a gene coding for a methionine-gastric lipase or a precursor of gastric lipase. The precursor protein is for example, pregastric lipase protein, or a fusion protein comprising gastric lipase and a heterologous protein. A pharmaceutical composition in unit dosage or liquid form is described.

## Claims

### Claim 1

An isolated gastric lipase protein from human gastric mucosal tissue.

### Claim 2 (depends on 1)

A fusion protein comprising the gastric lipase protein of claim 1 and a heterologous protein.

### Claim 3 (depends on 1)

The isolated gastric lipase protein of claim 1, wherein said gastric lipase protein is a methionine-gastric lipase protein from human gastric mucosal tissue.

### Claim 4 (depends on 3)

The isolated gastric lipase protein of claim 3 comprising the sequence:
Met-Leu-Phe-Gly-Lys-Leu-His-Pro-Gly-Ser-Pro-Glu-Val-Thr-Met-Asn-Ile-Ser-Gln -Met-Ile-Thr-Tyr-Trp-Gly-Tyr-Pro-Asn-Glu-Glu-Tyr-Glu-Val-Val-Thr-Glu-Asp-Gl y-Tyr-Ile-Leu-Glu-Val-Asn-Arg-Ile-Pro-Tyr-Gly-Lys-Lys-Asn-Ser-Gly-Asn-Thr-G ly-Gln-Arg-Pro-Val-Val-Phe-Leu-Gln-His-Gly-Leu-Leu-Ala-Ser-Ala-Thr-Trp-Trp- Ile-Ser-Asn-Leu-Pro-Asn-Asn-Ser-Leu-Ala-Phe-Ile-Leu-Ala-Asp-Ala-Gly-Tyr-Asp -Val-Trp-Leu-Gly-Asn-Ser-Arg-Gly-Asn-Thr-Trp-Ala-Arg-Arg-Asn-Leu-Tyr-Tyr-Se r-Pro-Asp-Ser-Val-Glu-Phe-Trp-Ala-Phe-Ser-Phe-Asp-Glu-Met-Ala-Lys-Tyr-Asp-L eu-Pro-Ala-Thr-Ile-Asp-Phe-Ile-Val-Lys-Lys-Thr-Gly-Gln-Lys-Gln-Leu-His-Tyr- Val-Gly-His-Ser-Gln-Gly-Thr-Thr-Ile-Gly-Phe-Ile-Ala-Phe-Ser-Thr-Asn-Pro-Ser -Leu-Ala-Lys-Arg-Ile-Lys-Thr-Phe-Tyr-Ala-Leu-Ala-Pro-Val-Ala-Thr-Val-Lys-Ty r-Thr-Lys-Ser-Leu-Ile-His-Lys-Leu-Arg-Phe-Val-Pro-Gln-Ser-Leu-Phe-Lys-Phe-I le-Phe-Gly-Asp-Lys-Ile-Phe-Tyr-Pro-His-Asn-Phe-Phe-Asp-Gln-Phe-Leu-Ala-Thr- Glu-Val-Cys-Ser-Arg-Glu-Met-Leu-Asn-Leu-Leu-Cys-Ser-Asn-Ala-Leu-Phe-Ile-Ile -Cys-Gly-Phe-Asp-Ser-Lys-Asn-Phe-Asn-Thr-Ser-Arg-Leu-Asp-Val-Tyr-Leu-Ser-Hi s-Asn-Pro-Ala-Gly-Thr-Ser-Val-Gln-Asn-Met-Phe-His-Trp-Thr-Gln-Ala-Val-Lys-S er-Gly-Lys-Phe-Gln-Ala-Tyr-Asp-Trp-Gly-Ser-Pro-Val-Gln-Asn-Arg-Met-His-Tyr- Asp-Gln-Ser-Gln-Pro-Pro-Tyr-Tyr-Asn-Val-Thr-Ala-Met-Asn-Val-Pro-Ile-Ala-Val -Trp-Asn-Gly-Gly-Lys-Asp-Leu-Leu-Ala-Asp-Pro-Gln-Asp-Val-Gly-Leu-Leu-Leu-Pr o-Lys-Leu-Pro-Asn-Leu-Ile-Tyr-His-Lys-Glu-Ile-Pro-Phe-Tyr-Asn-His-Leu-Asp-P he-Ile-Trp-Ala-Met-Asp-Ala-Pro-Gln-Glu-Val-Tyr-Asn-Asp-Ile-Val-Ser-Met-Ile- Ser-Glu-Asp-Lys-Lys.

### Claim 5 (depends on 1)

The isolated gastric lipase protein of claim 1 comprising the sequence:
Leu-Phe-Gly-Lys-Leu-His-Pro-Gly-Ser-Pro-Glu-Val-Thr-Met-Asn-Ile-Ser-Gln-Met -Ile-Thr-Tyr-Trp-Gly-Tyr-Pro-Asn-Glu-Glu-Tyr-Glu-Val-Val-Thr-Glu-Asp-Gly-Ty r-Ile-Leu-Glu-Val-Asn-Arg-Ile-Pro-Tyr-Gly-Lys-Lys-Asn-Ser-Gly-Asn-Thr-Gly-G ln-Arg-Pro-Val-Val-Phe-Leu-Gln-His-Gly-Leu-Leu-Ala-Ser-Ala-Thr-Trp-Trp-Ile- Ser-Asn-Leu-Pro-Asn-Asn-Ser-Leu-Ala-Phe-Ile-Leu-Ala-Asp-Ala-Gly-Tyr-Asp-Val -Trp-Leu-Gly-Asn-Ser-Arg-Gly-Asn-Thr-Trp-Ala-Arg-Arg-Asn-Leu-Tyr-Tyr-Ser-Pr o-Asp-Ser-Val-Glu-Phe-Trp-Ala-Phe-Ser-Phe-Asp-Glu-Met-Ala-Lys-Tyr-Asp-Leu-P ro-Ala-Thr-Ile-Asp-Phe-Ile-Val-Lys-Lys-Thr-Gly-Gln-Lys-Gln-Leu-His-Tyr-Val- Gly-His-Ser-Gln-Gly-Thr-Thr-Ile-Gly-Phe-Ile-Ala-Phe-Ser-Thr-Asn-Pro-Ser-Leu -Ala-Lys-Arg-Ile-Lys-Thr-Phe-Tyr-Ala-Leu-Ala-Pro-Val-Ala-Thr-Val-Lys-Tyr-Th r-Lys-Ser-Leu-Ile-His-Lys-Leu-Arg-Phe-Val-Pro-Gln-Ser-Leu-Phe-Lys-Phe-Ile-P he-Gly-Asp-Lys-Ile-Phe-Tyr-Pro-His-Asn-Phe-Phe-Asp-Gln-Phe-Leu-Ala-Thr-Glu- Val-Cys-Ser-Arg-Glu-Met-Leu-Asn-Leu-Leu-Cys-Ser-Asn-Ala-Leu-Phe-Ile-Ile-Cys -Gly-Phe-Asp-Ser-Lys-Asn-Phe-Asn-Thr-Ser-Arg-Leu-Asp-Val-Tyr-Leu-Ser-His-As n-Pro-Ala-Gly-Thr-Ser-Val-Gln-Asn-Met-Phe-His-Trp-Thr-Gln-Ala-Val-Lys-Ser-G ly-Lys-Phe-Gln-Ala-Tyr-Asp-Trp-Gly-Ser-Pro-Val-Gln-Asn-Arg-Met-His-Tyr-Asp- Gln-Ser-Gln-Pro-Pro-Tyr-Tyr-Asn-Val-Thr-Ala-Met-Asn-Val-Pro-Ile-Ala-Val-Trp -Asn-Gly-Gly-Lys-Asp-Leu-Leu-Ala-Asp-Pro-Gln-Asp-Val-Gly-Leu-Leu-Leu-Pro-Ly s-Leu-Pro-Asn-Leu-Ile-Tyr-His-Lys-Glu-Ile-Pro-Phe-Tyr-Asn-His-Leu-Asp-Phe-I le-Trp-Ala-Met-Asp-Ala-Pro-Gln-Glu-Val-Tyr-Asn-Asp-Ile-Val-Ser-Met-Ile-Ser- Glu-Asp-Lys-Lys.

### Claim 6 (depends on 1)

The isolated gastric lipase protein of claim 1, wherein said gastric lipase protein is a gastric lipase preprotein.

### Claim 7 (depends on 6)

The isolated gastric lipase protein of claim 6 comprising the sequence:
Met-Trp-Leu-Leu-Leu-Thr-Met-Ala-Ser-Leu-Ile-Ser-Val-Leu-Gly-Thr-Thr-His-Gly -Leu-Phe-Gly-Lys-Leu-His-Pro-Gly-Ser-Pro-Glu-Val-Thr-Met-Asn-Ile-Ser-Gln-Me t-Ile-Thr-Tyr-Trp-Gly-Tyr-Pro-Asn-Glu-Glu-Tyr-Glu-Val-Val-Thr-Glu-Asp-Gly-T yr-Ile-Leu-Glu-Val-Asn-Arg-Ile-Pro-Tyr-Gly-Lys-Lys-Asn-Ser-Gly-Asn-Thr-Gly- Gln-Arg-Pro-Val-Val-Phe-Leu-Gln-His-Gly-Leu-Leu-Ala-Ser-Ala-Thr-Trp-Trp-Ile -Ser-Asn-Leu-Pro-Asn-Asn-Ser-Leu-Ala-Phe-Ile-Leu-Ala-Asp-Ala-Gly-Tyr-Asp-Va l-Trp-Leu-Gly-Asn-Ser-Arg-Gly-Asn-Thr-Trp-Ala-Arg-Arg-Asn-Leu-Tyr-Tyr-Ser-P ro-Asp-Ser-Val-Glu-Phe-Trp-Ala-Phe-Ser-Phe-Asp-Glu-Met-Ala-Lys-Tyr-Asp-Leu- Pro-Ala-Thr-Ile-Asp-Phe-Ile-Val-Lys-Lys-Thr-Gly-Gln-Lys-Gln-Leu-His-Tyr-Val -Gly-His-Ser-Gln-Gly-Thr-Thr-Ile-Gly-Phe-Ile-Ala-Phe-Ser-Thr-Asn-Pro-Ser-Le u-Ala-Lys-Arg-Ile-Lys-Thr-Phe-Tyr-Ala-Leu-Ala-Pro-Val-Ala-Thr-Val-Lys-Tyr-T hr-Lys-Ser-Leu-Ile-His-Lys-Leu-Arg-Phe-Val-Pro-Gln-Ser-Leu-Phe-Lys-Phe-Ile- Phe-Gly-Asp-Lys-Ile-Phe-Tyr-Pro-His-Asn-Phe-Phe-Asp-Gln-Phe-Leu-Ala-Thr-Glu -Val-Cys-Ser-Arg-Glu-Met-Leu-Asn-Leu-Leu-Cys-Ser-Asn-Ala-Leu-Phe-Ile-Ile-Cy s-Gly-Phe-Asp-Ser-Lys-Asn-Phe-Asn-Thr-Ser-Arg-Leu-Asp-Val-Tyr-Leu-Ser-His-A sn-Pro-Ala-Gly-Thr-Ser-Val-Gln-Asn-Met-Phe-His-Trp-Thr-Gln-Ala-Val-Lys-Ser- Gly-Lys-Phe-Gln-Ala-Tyr-Asp-Trp-Gly-Ser-Pro-Val-Gln-Asn-Arg-Met-His-Tyr-Asp -Gln-Ser-Gln-Pro-Pro-Tyr-Tyr-Asn-Val-Thr-Ala-Met-Asn-Val-Pro-Ile-Ala-Val-Tr p-Asn-Gly-Gly-Lys-Asp-Leu-Leu-Ala-Asp-Pro-Gln-Asp-Val-Gly-Leu-Leu-Leu-Pro-L ys-Leu-Pro-Asn-Leu-Ile-Tyr-His-Lys-Glu-Ile-Pro-Phe-Tyr-Asn-His-Leu-Asp-Phe- Ile-Trp-Ala-Met-Asp-Ala-Pro-Gln-Glu-Val-Tyr-Asn-Asp-Ile-Val-Ser-Met-Ile-Ser -Glu-Asp-Lys-Lys.

### Claim 8 (depends on 1)

The isolated gastric lipase protein of claim 1 comprising the sequence:
Xaa-Leu-Phe-Gly-Lys-Leu-His-Pro-Gly-Ser-Pro-Glu-Val-Thr-Met-Asn-Ile-Ser-Gln -Met-Ile-Thr-Tyr-Trp-Gly-Tyr-Pro-Asn-Glu-Glu-Tyr-Glu-Val-Val-Thr-Glu-Asp-Gl y-Tyr-Ile-Leu-Glu-Val-Asn-Arg-Ile-Pro-Tyr-Gly-Lys-Lys-Asn-Ser-Gly-Asn-Thr-G ly-Gln-Arg-Pro-Val-Val-Phe-Leu-Gln-His-Gly-Leu-Leu-Ala-Ser-Ala-Thr-Trp-Trp- Ile-Ser-Asn-Leu-Pro-Asn-Asn-Ser-Leu-Ala-Phe-Ile-Leu-Ala-Asp-Ala-Gly-Tyr-Asp -Val-Trp-Leu-Gly-Asn-Ser-Arg-Gly-Asn-Thr-Trp-Ala-Arg-Arg-Asn-Leu-Tyr-Tyr-Se r-Pro-Asp-Ser-Val-Glu-Phe-Trp-Ala-Phe-Ser-Phe-Asp-Glu-Met-Ala-Lys-Tyr-Asp-L eu-Pro-Ala-Thr-Ile-Asp-Phe-Ile-Val-Lys-Lys-Thr-Gly-Gln-Lys-Gln-Leu-His-Tyr- Val-Gly-His-Ser-Gln-Gly-Thr-Thr-Ile-Gly-Phe-Ile-Ala-Phe-Ser-Thr-Asn-Pro-Ser -Leu-Ala-Lys-Arg-Ile-Lys-Thr-Phe-Tyr-Ala-Leu-Ala-Pro-Val-Ala-Thr-Val-Lys-Ty r-Thr-Lys-Ser-Leu-Ile-His-Lys-Leu-Arg-Phe-Val-Pro-Gln-Ser-Leu-Phe-Lys-Phe-I le-Phe-Gly-Asp-Lys-Ile-Phe-Tyr-Pro-His-Asn-Phe-Phe-Asp-Gln-Phe-Leu-Ala-Thr- Glu-Val-Cys-Ser-Arg-Glu-Met-Leu-Asn-Leu-Leu-Cys-Ser-Asn-Ala-Leu-Phe-Ile-Ile -Cys-Gly-Phe-Asp-Ser-Lys-Asn-Phe-Asn-Thr-Ser-Arg-Leu-Asp-Val-Tyr-Leu-Ser-Hi s-Asn-Pro-Ala-Gly-Thr-Ser-Val-Gln-Asn-Met-Phe-His-Trp-Thr-Gln-Ala-Val-Lys-S er-Gly-Lys-Phe-Gln-Ala-Tyr-Asp-Trp-Gly-Ser-Pro-Val-Gln-Asn-Arg-Met-His-Tyr- Asp-Gln-Ser-Gln-Pro-Pro-Tyr-Tyr-Asn-Val-Thr-Ala-Met-Asn-Val-Pro-Ile-Ala-Val -Trp-Asn-Gly-Gly-Lys-Asp-Leu-Leu-Ala-Asp-Pro-Gln-Asp-Val-Gly-Leu-Leu-Leu-Pr o-Lys-Leu-Pro-Asn-Leu-Ile-Tyr-His-Lys-Glu-Ile-Pro-Phe-Tyr-Asn-His-Leu-Asp-P he-Ile-Trp-Ala-Met-Asp-Ala-Pro-Gln-Glu-Val-Tyr-Asn-Asp-Ile-Val-Ser-Met-Ile- Ser-Glu-Asp-Lys-Lys, wherein Xaa comprises one or more amino acids.

### Claim 9 (depends on 1)

A pharmaceutical composition comprising the isolated gastric lipase protein of claim 1 and a pharmaceutically acceptable excipient.

### Claim 10 (depends on 2)

A pharmaceutical composition comprising the fusion protein of claim 2.

### Claim 11 (depends on 3)

A pharmaceutical composition comprising the isolated gastric lipase protein of claim 3 and a pharmaceutically acceptable excipient.

### Claim 12 (depends on 4)

A pharmaceutical composition comprising the isolated gastric lipase protein of claim 4 and a pharmaceutically acceptable excipient.

### Claim 13 (depends on 5)

A pharmaceutical composition comprising the isolated gastric lipase protein of claim 5 and a pharmaceutically acceptable excipient.

### Claim 14 (depends on 6)

A pharmaceutical composition comprising the isolated gastric lipase protein of claim 6 and a pharmaceutically acceptable excipient.

### Claim 15 (depends on 7)

A pharmaceutical composition comprising the isolated gastric lipase protein of claim 7 and a pharmaceutically acceptable excipient.

### Claim 16 (depends on 8)

A pharmaceutical composition comprising the isolated gastric lipase protein of claim 8 and a pharmaceutically acceptable excipient.
